ConductScience.org, home

Paper40410550

LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision.

Hamdy NM and 7 others. Naunyn Schmiedebergs Arch Pharmacol, 2025. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision. Papers, record 40410550. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40410550

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision.
PubMed
Journal
Naunyn Schmiedebergs Arch Pharmacol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
3.77, provisional
iCite
Revised in PubMed
2025-10-27
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hamdy NMNadia Mhttps://orcid.org/0000-0003-2105-107X
2Sallam AMAl-Aliaa M
3Elazazy OOla
4Kabel AMAhmed M
5Salama RMRania Mhttps://orcid.org/0000-0002-1873-6222
6Gouhar SAShaimaa A
7El-Daly SMSherien M
8Darwish SFSamar Fhttps://orcid.org/0000-0002-4238-7069

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
RNA, Long NoncodingMajor topic
MicroRNAsMajor topic
Humans
Animals
Gene Expression Regulation, Neoplastic
Computer Simulation

Source PubMed

Download CSV of topics

References223

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126547929Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.Oncotarget2015https://conductscience.org/library/papers/26547929PubMed
234636091Long noncoding RNA Gas5 induces cell apoptosis and inhibits tumor growth via activating the CHOP-dependent endoplasmic reticulum stress pathway in human hepatoblastoma HepG2 cells.J Cell Biochem2022https://conductscience.org/library/papers/34636091PubMed
334504432Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases.Front Pharmacol2021https://conductscience.org/library/papers/34504432PubMed
428129650MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway.Oncotarget2017https://conductscience.org/library/papers/28129650PubMed
537101621Nanoconjugated long non-coding RNA MEG3 as a new therapeutic approach for Hepatocellular carcinoma.Heliyon2023https://conductscience.org/library/papers/37101621PubMed
631954487Advances in molecular classification and precision oncology in hepatocellular carcinoma.J Hepatol2020https://conductscience.org/library/papers/31954487PubMed
734907204LncRNA LINC00667 aggravates the progression of hepatocellular carcinoma by regulating androgen receptor expression as a miRNA-130a-3p sponge.Cell Death Discov2021https://conductscience.org/library/papers/34907204PubMed
838013127LINC02561 promotes metastasis in HCC via HIF1-α/NDRG1/UPF1 axis.Gene2024https://conductscience.org/library/papers/38013127PubMed
936596869Long non-coding RNAs: definitions, functions, challenges and recommendations.Nat Rev Mol Cell Biol2023https://conductscience.org/library/papers/36596869PubMed
1039674644In silico and cheminformatics prediction with experimental validation of an adipogenesis cocktail, sorafenib with rosiglitazone for HCC dedifferentiation.J Genet Eng Biotechnol2024https://conductscience.org/library/papers/39674644PubMed
1122512580Hypoxia-inducible factor-1alpha: molecular-targeted therapy for hepatocellular carcinoma.Mini Rev Med Chem2013https://conductscience.org/library/papers/22512580PubMed
1232854717Roles of METTL3 in cancer: mechanisms and therapeutic targeting.J Hematol Oncol2020https://conductscience.org/library/papers/32854717PubMed
1332295598The role of long noncoding RNAs in hepatocellular carcinoma.Mol Cancer2020https://conductscience.org/library/papers/32295598PubMed
1436560421Multi-Epitope Vaccine Design against Monkeypox Virus via Reverse Vaccinology Method Exploiting Immunoinformatic and Bioinformatic Approaches.Vaccines (Basel)2022https://conductscience.org/library/papers/36560421PubMed
1530632031The anti-tumor activity of brown seaweed oligo-fucoidan via lncRNA expression modulation in HepG2 cells.Cytotechnology2019https://conductscience.org/library/papers/30632031PubMed
1629568237Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.Cancer Cell Int2018https://conductscience.org/library/papers/29568237PubMed
1733116873Regulatory Networks of LncRNA MALAT-1 in Cancer.Cancer Manag Res2020https://conductscience.org/library/papers/33116873PubMed
1832164265Inflammatory Mechanisms of HCC Development.Cancers (Basel)2020https://conductscience.org/library/papers/32164265PubMed
1936293412Cytotoxic T Cell Expression of Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) in Viral Hepatitis C-Mediated Hepatocellular Carcinoma.Int J Mol Sci2022https://conductscience.org/library/papers/36293412PubMed
2029803923The association of lncRNA-HULC polymorphisms with hepatocellular cancer risk and prognosis.Gene2018https://conductscience.org/library/papers/29803923PubMed

See all 223 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42488711Cell-cycle reactivation and hepatocyte identity loss in hepatocellular carcinoma: Transcriptomic hallmarks and validation strategies (Review).Oncol Lett2026https://conductscience.org/library/papers/42488711PubMed
42480981A Potential miR-1246-5p-H3K27ac-NOL12 Regulatory Axis and Its Putative Tumour-Promoting Function in Hepatocellular Carcinoma.IET Syst Biol2026https://conductscience.org/library/papers/42480981PubMed
42453334From In Silico to Clinic: Harnessing Noncoding RNAs for Diabetes Research and Therapy, a Step toward ncRNA Precision.ACS Pharmacol Transl Sci2026https://conductscience.org/library/papers/42453334PubMed
42180949Identification of EFNA family as new potential prognostic biomarkers correlated with immune cell infiltration in hepatocellular carcinoma.Transl Cancer Res2026https://conductscience.org/library/papers/42180949PubMed
42147940Hepatocellular carcinoma with extensive fatty change: a case description.Quant Imaging Med Surg2026https://conductscience.org/library/papers/42147940PubMed
42041104RTA‑408 induces p38‑dependent apoptosis and suppresses cell viability in hepatocellular carcinoma cells.Hepat Oncol2026https://conductscience.org/library/papers/42041104PubMed
42002886Meox1 promotes hepatocellular carcinoma progression potentially via regulation of cell cycle and p21 expression.Cell Adh Migr2026https://conductscience.org/library/papers/42002886PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40410550

GET https://conductscience.org/api/papers/v1/40410550/references?page=2